Detalhe da pesquisa
1.
Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening.
Clin Gastroenterol Hepatol
; 21(13): 3424-3432.e2, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37619823
2.
Colonoscopy-Related Mortality in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
Clin Gastroenterol Hepatol
; 19(7): 1418-1425, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777553
3.
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
Int J Cancer
; 147(4): 1098-1106, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31853977
4.
The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance.
United European Gastroenterol J
; 11(9): 894-903, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854002
5.
Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
PLoS One
; 17(6): e0270223, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35749423
6.
Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine.
Eur J Gastroenterol Hepatol
; 20(1): 68-72, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18090994
7.
The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors.
PLoS One
; 9(7): e100187, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25033446